Zhitong Finance App News, Jiuqiang Biotech (300406.SZ) issued an announcement. The company recently received the “Medical Device Registration Certificate” issued by the Beijing Drug Administration. The product is a type I collagen amino terminal lengthening peptide test kit (magnetic particle chemiluminescence immunoassay). This kit is used to quantitatively measure the content of type I collagen amino-terminal lengthening peptide (Total-P1NP) in human serum or plasma in vitro. The acquisition of the above registration certificate has enriched the company's product line in the field of in vitro diagnostic chemiluminescence segments, and is conducive to further enhancing the company's core competitiveness and market expansion capabilities.

Disclaimer:Webull uses external vendor Google Translation Service for news translations where we endeavour to ensure these are correct, however, we recommend that you please double-check this information accordingly. Webull is not responsible for translation errors or issues.